Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 08, 2023

BUY
$12.53 - $21.71 $14,121 - $24,467
1,127 Added 20.67%
6,580 $88,000
Q4 2022

Feb 01, 2023

BUY
$11.61 - $16.11 $7,987 - $11,083
688 Added 14.44%
5,453 $67,000
Q2 2022

Aug 09, 2022

SELL
$11.23 - $19.59 $1,280 - $2,233
-114 Reduced 2.34%
4,765 $66,000
Q1 2022

Apr 21, 2022

BUY
$13.37 - $17.79 $25,443 - $33,854
1,903 Added 63.94%
4,879 $79,000
Q2 2020

Jul 28, 2020

BUY
$46.7 - $92.04 $41,843 - $82,467
896 Added 43.08%
2,976 $143,000
Q1 2020

May 06, 2020

BUY
$48.35 - $118.68 $15,085 - $37,028
312 Added 17.65%
2,080 $131,000
Q3 2019

Oct 18, 2019

BUY
$58.69 - $80.46 $31,633 - $43,367
539 Added 43.86%
1,768 $117,000
Q1 2019

Apr 29, 2019

SELL
$91.83 - $120.68 $17,172 - $22,567
-187 Reduced 13.21%
1,229 $137,000
Q4 2018

Jan 25, 2019

BUY
$85.79 - $126.46 $15,699 - $23,142
183 Added 14.84%
1,416 $143,000
Q3 2018

Nov 09, 2018

BUY
$88.49 - $127.55 $15,839 - $22,831
179 Added 16.98%
1,233 $156,000
Q4 2017

Jan 31, 2018

BUY
$58.2 - $72.76 $20,428 - $25,538
351 Added 49.93%
1,054 $62,000
Q3 2017

Nov 08, 2017

BUY
$57.01 - $118.75 $40,078 - $83,481
703
703 $41,000

Others Institutions Holding ICPT

About INTERCEPT PHARMACEUTICALS, INC.


  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.